Surgical treatment of metastatic pulmonary soft-tissue sarcoma.
The lung is the most frequent site of metastasis from soft-tissue sarcomas. Due to the relative resistance of sarcoma to either chemotherapy or radiotherapy, compared to other solid tumors, surgical management of pulmonary metastases has been a pivotal therapy in this disease. With decades of experience in numerous centers, criteria for patient selection have been ascertained and documented. We review the current literature on the use of pulmonary metastasectomy in patients with soft-tissue sarcoma, as well as survival data after such treatment. Osteogenic sarcoma is not included in this discussion.
Chao
C
C
Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Goldberg
M
M
D014408:Biomarkers, Tumor; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D009364:Neoplasm Recurrence, Local; D018579:Patient Selection; D011379:Prognosis; D012509:Sarcoma / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D012983:Soft Tissue Neoplasms / Q000473:pathology*; D015996:Survival Rate
D014408:Biomarkers, Tumor